Cytokine-induced sickness behavior: where do we stand?
- PMID: 11259077
- DOI: 10.1006/brbi.2000.0613
Cytokine-induced sickness behavior: where do we stand?
Abstract
Sickness behavior refers to the coordinated set of behavioral changes that develop in sick individuals during the course of an infection. At the molecular level, these changes are due to the effects of proinflammatory cytokines, such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNFalpha), in the brain. Peripherally released cytokines act on the brain via a fast transmission pathway involving primary afferent nerves innervating the body site of inflammation and a slow transmission pathway involving cytokines originating from the choroid plexus and circumventricular organs and diffusing into the brain parenchyma by volume transmission. At the behavioral level, sickness behavior appears to be the expression of a central motivational state that reorganizes the organism's priorities to cope with infectious pathogens. There is clinical and experimental evidence that activation of the brain cytokine system is associated with depression, although the exact relationship between sickness behavior and depression is still elusive.
Similar articles
-
Cytokine-induced sickness behavior: mechanisms and implications.Ann N Y Acad Sci. 2001 Mar;933:222-34. doi: 10.1111/j.1749-6632.2001.tb05827.x. Ann N Y Acad Sci. 2001. PMID: 12000023 Review.
-
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity.Eur J Pharmacol. 2004 Oct 1;500(1-3):399-411. doi: 10.1016/j.ejphar.2004.07.040. Eur J Pharmacol. 2004. PMID: 15464048 Review.
-
Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms.Oncol Nurs Forum. 2008 Sep;35(5):802-7. doi: 10.1188/08.ONF.802-807. Oncol Nurs Forum. 2008. PMID: 18765326 Review.
-
[Current studies on the neurobiology of chronic fatigue syndrome].Encephale. 1994 Nov;20 Spec No 3:597-602. Encephale. 1994. PMID: 7843056 Review. French.
-
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences.Neurol Clin. 2006 Aug;24(3):521-38. doi: 10.1016/j.ncl.2006.03.010. Neurol Clin. 2006. PMID: 16877122 Review.
Cited by
-
Correlation of biochemical markers and inflammatory cytokines in autism spectrum disorder (ASD).BMC Pediatr. 2024 Nov 1;24(1):696. doi: 10.1186/s12887-024-05182-3. BMC Pediatr. 2024. PMID: 39487445 Free PMC article.
-
Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches.Curr Top Behav Neurosci. 2017;31:117-138. doi: 10.1007/7854_2016_6. Curr Top Behav Neurosci. 2017. PMID: 27225497 Free PMC article. Review.
-
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors.EJC Suppl. 2013 Sep;11(2):172-91. doi: 10.1016/j.ejcsup.2013.07.016. EJC Suppl. 2013. PMID: 26217127 Free PMC article. Review. No abstract available.
-
Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine.Front Psychiatry. 2024 Jun 13;15:1422939. doi: 10.3389/fpsyt.2024.1422939. eCollection 2024. Front Psychiatry. 2024. PMID: 38938457 Free PMC article. Review.
-
Sleep and immune function: glial contributions and consequences of aging.Curr Opin Neurobiol. 2013 Oct;23(5):806-11. doi: 10.1016/j.conb.2013.02.003. Epub 2013 Feb 26. Curr Opin Neurobiol. 2013. PMID: 23452941 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
